Geode Capital Management’s Tyra Biosciences TYRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.43M | Buy |
567,126
+50,836
| +10% | +$487K | ﹤0.01% | 2685 |
|
|
2025
Q1 | $4.8M | Sell |
516,290
-1,288
| -0.2% | -$12K | ﹤0.01% | 2675 |
|
|
2024
Q4 | $7.2M | Sell |
517,578
-5,612
| -1% | -$78K | ﹤0.01% | 2550 |
|
|
2024
Q3 | $12.3M | Buy |
523,190
+516
| +0.1% | +$12.1K | ﹤0.01% | 2261 |
|
|
2024
Q2 | $8.36M | Buy |
522,674
+105,866
| +25% | +$1.69M | ﹤0.01% | 2436 |
|
|
2024
Q1 | $6.84M | Buy |
416,808
+83,339
| +25% | +$1.37M | ﹤0.01% | 2534 |
|
|
2023
Q4 | $4.62M | Buy |
333,469
+18,991
| +6% | +$263K | ﹤0.01% | 2746 |
|
|
2023
Q3 | $4.33M | Buy |
314,478
+24,480
| +8% | +$337K | ﹤0.01% | 2716 |
|
|
2023
Q2 | $4.94M | Buy |
289,998
+3,894
| +1% | +$66.3K | ﹤0.01% | 2679 |
|
|
2023
Q1 | $4.6M | Buy |
286,104
+32,412
| +13% | +$521K | ﹤0.01% | 2665 |
|
|
2022
Q4 | $1.93M | Buy |
253,692
+6,242
| +3% | +$47.4K | ﹤0.01% | 3057 |
|
|
2022
Q3 | $2.18M | Buy |
247,450
+22,039
| +10% | +$194K | ﹤0.01% | 3058 |
|
|
2022
Q2 | $1.61M | Buy |
225,411
+14,862
| +7% | +$106K | ﹤0.01% | 3192 |
|
|
2022
Q1 | $2.25M | Buy |
210,549
+4,168
| +2% | +$44.6K | ﹤0.01% | 3206 |
|
|
2021
Q4 | $2.9M | Buy |
+206,381
| New | +$2.9M | ﹤0.01% | 3187 |
|